Arkolith/Insider Trading/HRTX/Form 4

Morgan Adam

DirectorHERON THERAPEUTICS, INC. /DE/ (HRTX) · full profile →Form 4 · filed Jul 25, 2023
Net Buying
Open-Market Buys
$3.4M
Open-Market Sells
$0
Net Open-Market Flow
$3.4M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2023Buy(P)2.5M$1.37$3.4M7.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2023Buy(P)1.2M$1.37$1.6M1.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-23-001721) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML